Our 2021 application cycle is now open for MedTech Innovator. All early and mid-stage medical device, diagnostic, and digital health companies are eligible to apply. Companies do not have to relocate, and there is no equity required or fee for participation.
Benefits of the program include: high profile visibility to healthcare investors and decision makers, access to a best-in-class network of mentors and peers, and participation in a customized virtual curriculum.
Startups and scaleups interested in applying have until Friday, January 15, 2021 to submit an application. Early entry is recommended for priority reviews.
Please help us spread the word by forwarding this newsletter to outstanding companies and posting the application link below on social media:
From the Innovator's Workbench: A Tracy Lefteroff Memorial Event
Scott Gottlieb is keen observer of the promise and limitations of technology and public health. He served as the 23rd commissioner of the FDA from 2017-2019 and is currently a resident fellow at the American Enterprise Institute and a special partner at the venture capital firm New Enterprise Associates. In this conversations with David Cassak, co-editor-in-chief of MedTech Strategist, Dr. Gottlieb will share his perspective on the challenged of regulating technologies and medicines during COVID-19 and discuss implications for the development and assessment of health technologies going forward.
The 2021 Bay Area Biomedical Device Conference will be held on Tuesday and Wednesday, March 30-31, 2021 from 8:00 a.m. to 1:00 p.m. on both days. The Conference will be held virtually through Gatherly; more information about how to access and use Gatherly will be available soon